🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will assess the efficacy and safety of mosunetuzumab in combinat...
Status
Active Not Recruiting
Location
City of Hope Cancer Center
Start Date
2022-04-25
Trial ID
NCT05171647
Treatments Being Tested
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (...
Status
Active Not Recruiting
Location
The University of Arizona Cancer Center - North Campus /ID# 242219
Start Date
2022-06-14
Trial ID
NCT05283720
This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2023-06-12
Trial ID
NCT05633615
This is a phase ll study of participants with untreated diffuse large B Cel...
Status
Recruiting
Location
Princess Margaret Cancer Centre
Start Date
2025-01-24
Trial ID
NCT06050694
Treatments Being Tested
In the present trial the chemotherapy- light treatment concept R-Pola-Glo w...
Status
Active Not Recruiting
Location
Uniklinik Innsbruck
Start Date
2023-03-20
Trial ID
NCT05798156
Treatments Being Tested
This is a prospective, multicenter, single-arm, open phase II study to expl...
Status
Recruiting
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2024-08-31
Trial ID
NCT06554600
Treatments Being Tested
This phase I/Ib trial studies the side effects and best dose of parsaclisib...
Status
Active Not Recruiting
Location
Mayo Clinic in Arizona
Start Date
2020-06-15
Trial ID
NCT04323956
This study is a prospective, open-label, multicenter study in previously un...
Status
Recruiting
Location
The Affiliated Hospital of Xuzhou Medical University
Start Date
2026-03-01
Trial ID
NCT07680933
Treatments Being Tested
This is a prospective, open-label, multicenter, randomized controlled study...
Status
Not Yet Recruiting
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2026-05-06
Trial ID
NCT07594899
This is a Phase I, multicenter, open-label, dose-escalation study of polatu...
Status
Completed
Location
Stanford Cancer Center
Start Date
2011-03-22
Trial ID
NCT01290549
Treatments Being Tested